analgesia for hip surgery

Pericapsular Nerve Group Block VS Femoral Nerve Block in Hip Surgery: Comparative Study, Double Blind Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202211633784671

Enrollment

Registered

2022-11-24

Start date

2022-12-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

femoral nerve block

Pericapsular Nerve Group Block

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with a hip fracture presenting for surgery, aged 45 years and older, without contraindications for regional anesthesia.

Exclusion criteria

Exclusion criteria: 1. Patients with uncontrolled hypertension, hyperthyroidism or severe dementia 2. allergy to ropivacaine 3. Regional anatomical abnormalities or infections at the site of block. 4. Bleeding disorders e.g., thrombocytopenia, high INR, high PT in patients known to have chronic liver disease or impaired kidney. 5. Patients on chronic pain medications or regularly receiving analgesics. 6. Patients with high kidney functions e.g., high serum creatinine level.

Design outcomes

Primary

Measure	Time frame
•The postoperative NRS pain score will be followed up for 34 hours postoperatively.	—

Secondary

Measure	Time frame
• NRS pain scores on day 1 postoperatively. • Postoperative quadriceps strength. o Quadriceps strength will be assessed using the knee extension test11 and Oxford muscle strength grading12 with grouped scores of intact (5/5), reduced (1-4/5) and absent (0/5). • Perioperative opiate use. o Opiate use will be reported as use intraoperatively, on day 0, first request of analgesia postoperatively, and total use of analgesia for 6 hours postoperatively will be reported. o PCA would be used for patient when needed with bolus dose of 50 mcg and infusion rate of = 10mcg/h of fentanyl, total dose of fentanyl administered to the patient over 6 hours postoperatively and its onset of action will be reported. • Postoperative complications. • Time of first request of analgesia and dosage. • Length of hospital stay. • patient satisfaction and patient-reported outcomes measures (PROMs). o On day 1, parameters of patient satisfaction, pain experienced, and quality of recovery will be evaluated using the Patient-Reported Outcomes Measurement Information System (PROMIS) item banks for evaluation of depression and pain interference, Brief Pain Inventory (BPI) and the Quality of Recovery (QoR-15) questionnaires (Appendix 1). o The APS assessed patient satisfaction and pain management on day 1. o Patients will be asked to recall the time the block wore off, defined as return of motor (if initially impaired) and/or sensory recovery.	—

Measure

Time frame

• NRS pain scores on day 1 postoperatively. • Postoperative quadriceps strength. o Quadriceps strength will be assessed using the knee extension test11 and Oxford muscle strength grading12 with grouped scores of intact (5/5), reduced (1-4/5) and absent (0/5). • Perioperative opiate use. o Opiate use will be reported as use intraoperatively, on day 0, first request of analgesia postoperatively, and total use of analgesia for 6 hours postoperatively will be reported. o PCA would be used for patient when needed with bolus dose of 50 mcg and infusion rate of = 10mcg/h of fentanyl, total dose of fentanyl administered to the patient over 6 hours postoperatively and its onset of action will be reported. • Postoperative complications. • Time of first request of analgesia and dosage. • Length of hospital stay. • patient satisfaction and patient-reported outcomes measures (PROMs). o On day 1, parameters of patient satisfaction, pain experienced, and quality of recovery will be evaluated using the Patient-Reported Outcomes Measurement Information System (PROMIS) item banks for evaluation of depression and pain interference, Brief Pain Inventory (BPI) and the Quality of Recovery (QoR-15) questionnaires (Appendix 1). o The APS assessed patient satisfaction and pain management on day 1. o Patients will be asked to recall the time the block wore off, defined as return of motor (if initially impaired) and/or sensory recovery.

—

Countries

Egypt

Contacts

Public Contacthossam atef

associate prof

hossamatef@med.suez.edu.eg02001064663086

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026